Showing 671-680 of 4705 results for "".
FDA Follow-Up Study Reignites Sunscreen Safety Debate
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/fda-follow-up-study-reignites-sunscreen-safety-debate/23219/CSF faculty weigh in on the meaning of recent sunscreen studies.The State of Academic Dermatology
https://practicaldermatology.com/topics/practice-management/the-state-of-academic-dermatology/18843/In this edition of Derm Insider, host Neal Bhatia, MD sits down with Jane Grant-Kels, MD, Sheila Fallon Friedlander, MD, and Kevin Cooper, MD to discuss the challenges and rewards of academic dermatology. From meeting aggressive budgets to dealing with EMRs, academicians face many of the same demandPart 3, 1726 nm lasers: How to talk to patients about incorporating the 1726 nm wavelength lasers into their treatment regimens: Hint is to be patient
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24341/Chapter 3 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about how to talk to patients about incorporating the 1726 nm wavelength lasers into their treatment regimens: Hint is toQuarantine Quorum: Circling the Wagons
https://practicaldermatology.com/topics/practice-management/quarantine-quorum-circling-the-wagons/18180/With Quarantine Quorum, host Neal Bahtia, MD provides a diary of life during the COVID-19 pandemic, talking to members of the dermatology community as they adapt to ongoing changes in their personal and private lives. In this edition, Hilary Baldwin, MD; Adam J. Friedman, MD; Mark Kaufmann, MD; andWhat’s In My Black Bag?
https://practicaldermatology.com/topics/practice-management/whats-in-my-black-bag/23651/CSF faculty member Jeanine Downie, MD dishes on her favorite products.GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muDear New Resident; CSF Grants Available
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dear-new-resident-csf-grants-available/20458/What 50 Years Ago Means for Today
https://practicaldermatology.com/topics/practice-management/what-50-years-ago-means-for-today/20476/New Drugs and Therapies in 2025: Dr. Bhatia
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/new-drugs-and-therapies-in-2025-dr-bhatia/32688/Neal Bhatia, MD, discusses the drugs, devices, and more that he and Ted Rosen, MD, presented during "New Drugs and Therapies in 2025" at Maui Derm 2025.Journal Club: Pediatric Treatment Adherence
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-pediatric-treatment-adherence/32401/Practical Dermatology Editorial Board members Lawrence Eichenfield, MD, FAAD, Jason Hawkes, MD, MS FAAD, discuss the article "Treatment Adherence in Pediatric Atopic Dermatitis: A Systemic Review," from Pediatric Dermatology as well as their favorite strategies for treatment adherence and the impact